Literature DB >> 25837333

[Continuity of care: the concordance of discharge planning between public and private hospitals and district].

Franco Cirio.   

Abstract

INTRODUCTION: A good post hospital discharge planning facilitates the discharge, improves patients' health conditions and decreases the social costs. AIM: To assess the agreement of the discharge settings suggested by the public or private hospitals and by the district.
METHOD: A random sample of 318 over 1152 discharge reports send in 2013 by Hospitals to the District service of ASLTO2 - Piedmont Region was selected.
RESULTS: The agreement for discharge planning between public hospitals and District was 57.4% (50% for private hospitals), with differences according to the discharge setting: 75.3% for Home care, 61.3% for Nursing Homes, 44.4% long term rehabilitation, 42.9% for the Hospice and only 7.4% for specialized Nursing Homes. Reasons for lack of agreement were an inappropriate assessment of patients or family resources and of discharge settings.
CONCLUSIONS: The District is in a better position for assessing the range services to be offered the to patients, their living and family conditions and thus, to identify the most suitable post discharge settings.

Entities:  

Mesh:

Year:  2015        PMID: 25837333     DOI: 10.1702/1812.19750

Source DB:  PubMed          Journal:  Assist Inferm Ric        ISSN: 1592-5986            Impact factor:   0.804


  2 in total

1.  A multidimensional vector model measuring clinical complexity may increase effectiveness in patient assessment.

Authors:  Alvisa Palese; Silvio Brusaferro
Journal:  Intern Emerg Med       Date:  2017-08-04       Impact factor: 3.397

2.  Information before discharge in geriatric patients in Italy: cultural adaptation and validation of the Patient Continuity of Care Questionnaire.

Authors:  Gabriella Facchinetti; Michela Piredda; Davide Ausili; Veronica Angaroni; Beatrice Albanesi; Anna Marchetti; Stefania Di Mauro; Maria Grazia De Marinis
Journal:  Eur J Ageing       Date:  2020-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.